1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells

This publication has 29 references indexed in Scilit:

• Topical calcipotriol treatment in advanced breast cancer
  The Lancet, 1991
• Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin
  Journal of Endocrinology, 1989
• 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses concanavalin A-stimulated human T cell proliferation through monocytes
  Clinical Immunology and Immunopathology, 1989
• POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
  The Lancet, 1989
• 1,25-DIHYDROXYVITAMIN D3 ENHANCES THYROTROPIN RELEASING HORMONE INDUCED THYROTROPIN SECRETION IN NORMAL PITUITARY CELLS
  Endocrinology, 1987
• Vitamin D and the immune system
  Steroids, 1987
• Effects of vitamin D3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts culturedin vitro
  Calcified Tissue International, 1984
• 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism.
  Proceedings of the National Academy of Sciences, 1983
• Corticosteroid‐Mediated Immunoregulation in Man
  Immunological Reviews, 1982
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982